Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

Thyroid cancer

DW Chen, BHH Lang, DSA McLeod, K Newbold… - The Lancet, 2023 - thelancet.com
The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology

RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Thyroid cancer incidence trends by histology in 25 countries: a population-based study

A Miranda-Filho, J Lortet-Tieulent, F Bray… - The lancet Diabetes & …, 2021 - thelancet.com
Background The incidence of thyroid cancer has increased in different populations
worldwide in the past 30 years. We present here an overview of international trends of …

WITHDRAWN: The 2023 Bethesda System for Reporting Thyroid Cytopathology

SZ Ali, ZW Baloch, B Cochand-Priollet, FC Schmitt… - 2023 - Elsevier
Since the publication of the 1st edition in 2010, The Bethesda System for Reporting Thyroid
44 Cytopathology (TBSRTC) has allowed cytopathologists to use a standardized, category …

[HTML][HTML] Environmental pollution, a hidden culprit for health issues

H Xu, Y Jia, Z Sun, J Su, QS Liu, Q Zhou… - Eco-Environment & …, 2022 - Elsevier
The environmental and health impacts from the massive discharge of chemicals and
subsequent pollution have been gaining increasing public concern. The unintended …

Thyroid cancer incidence and mortality trends in the United States: 2000–2018

UC Megwalu, PK Moon - Thyroid, 2022 - liebertpub.com
Background: Thyroid cancer incidence has significantly increased in the United States over
the past few decades. Recent studies have suggested a change in thyroid cancer incidence …

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer

S Leboulleux, C Bournaud, CN Chougnet… - … England Journal of …, 2022 - Mass Medical Soc
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

[HTML][HTML] 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean Society of Thyroid Radiology consensus …

EJ Ha, SR Chung, DG Na, HS Ahn… - Korean journal of …, 2021 - ncbi.nlm.nih.gov
Incidental thyroid nodules are commonly detected on ultrasonography (US). This has
contributed to the rapidly rising incidence of low-risk papillary thyroid carcinoma over the last …

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial

MS Brose, B Robinson, SI Sherman… - The Lancet …, 2021 - thelancet.com
Background Patients with radioiodine-refractory differentiated thyroid cancer (DTC)
previously treated with vascular endothelial growth factor receptor (VEGFR)-targeted …